Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1252-1261

  Bowman, W P ^a   Shuster, J J ^a   Cook, B ^a   Griffin, T ^a   Behm, F ^a   Pullen, J ^a   Link, M ^a   Head, D ^a   Carroll, A ^a   Berard, C ^a   Murphy, S ^a  

^a Risk Evaluation to Achieve Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; FEMALE; HUMAN; INFECTION RISK; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PANCYTOPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 9244240250     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1252     Document Type: Article

References (26)

1. Roath S: Acute lymphoblastic leukaemia of B-cell origin. Clin Lab Haematol 1:87-94, 1979
2. Magrath IT, Ziegler JL: Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia. Leuk Res 4:33-59, 1979
3. Anderson JA, Wilson JF, Jenkin RDT, et al: Childhood non-Hodgkin's lymphoma: The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 308:559-565, 1983
4. Magrath IT, Janus C, Edwards BK, et al: An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63:1102-1111, 1984
5. Sullivan MP, Ramirez I: Curability of Burkitt's lymphoma with high-close cyclophosphamide - high-dose methotrexate therapy with intrathecal chemoprophylaxis. J Clin Oncol 3:627-636, 1985
6. +) acute lymphoblastic leukemia with high-dose methotrexate and cytarahine. J Clin Oncol 4:1732-1739, 1986
7. Sullivan MP, Brecher M, Ramirez I, et al: High-dose cyclophosphamide-high dose methotrexate with coordinated intrathecal chemotherapy for advanced non-lymphoblastic lymphoma of childhood: Results of a Pediatric Oncology Group study. Am J Pediatr Hematol Oncol 13:288-295, 1991
8. Murphy SB: Management of childhood non-Hodgkin's lymphoma. Cancer Treat Rep 61:1161-1177, 1977
9. National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
10. Kelly DR, Nathwani BN, Griffith RC, et al: A morphologic study of childhood lymphoma of the undifferentiated type. Cancer 59:1132-1137, 1987
11. Hutchison RE, Murphy SB, Fairclough DL, et al: Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Cancer 64:23-28, 1989
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
14. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135:185-198, 1972
15. Griffin TC, Bowman WP, Shuster J, et al: High prevalence of orofacial symptoms in non-African children with B-cell acute lymphocytic leukemia (B-ALL) and stage IV diffuse, undifferentiated lymphoma (DUL). Med Pediatr Oncol 21:534, 1993 (abstr)
16. Griffin TC, Bowman WP, Winick NJ, et al: Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: Further experience with total therapy B. Med Pediatr Oncol 23:393-399, 1994
17. Patte C, Philip T, Rodary C, et al: Improved survival rate in children with stage III and IV B-cell non-Hodgkin's lymphoma and leukemia using multiagent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 4:1219-1226, 1986
18. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphoma and leukemia without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
19. Patte C, Michon J, Leverger G, et al: High survival rate of childhood B-cell lymphoma and leukemia (ALL) as result of the LMB 89 protocol of the SFOP. Med Pediatr Oncol 21:531, 1993 (abstr)
20. Reiter A, Schrappe M, Ludwig W-D, et al: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 80:2471-2478, 1992
21. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage-A report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 13:359-372, 1995
22. Hann IM, Eden OB, Barnes J, et al: "MACHO" chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. Br J Hematol 76:359-364, 1990
23. Finlay JL, Trigg ME, Link MP, et al: Poor-risk nonlymphoblastic lymphoma of childhood: Results of an intensive pilot study. Med Pediatr Oncol 17:29-38, 1989
24. Schwenn MR, Blattner SR, Lynch E, et al: HICCOM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133-138, 1991
25. Patte C, Leverger G, Perel Y, et al: Results of LMB 86 and 89 protocols of the French Pediatric Oncology Society (S.F.O.P.) for children with B-cell lymphoma and leukemia with CNS involvement (CNS+). Med Pediatr Oncol 21:535, 1993 (abstr)
26. Magrath IT, Adde M, Shad A, et al: A new short duration chemotherapy protocol for the treatment of small noncleaved cell (SNCC) and large cell (LC) lymphomas. Proc Am Soc Clin Oncol 12:385, 1993 (abstr)